Development of gadolinium based nanoparticles having an affinity towards melanin

Nanoscale

Volumn 5, Issue 4, 2013, Pages 1603-1615

  Morlieras, Jessica ^a   Chezal, Jean Michel ^b,c,d   Miot Noirault, Elisabeth ^b,c,d   Roux, Amandine ^e,f   Heinrich Balard, Laurence ^e,f   Cohen, Richard ^e,f,g   Tarrit, Sébastien ^b,c,d   Truillet, Charles ^a   Mignot, Anna ^a,f,h   Hachani, Roxanne ^a   Kryza, David ^a,g   Antoine, Rodolphe ^e   Dugourd, Philippe ^e   Perriat, Pascal ^f   Janier, Marc ^a,g   Sancey, Lucie ^a   Lux, François ^a   Tillement, Olivier ^a  

^a UNIVERSITÉ DE LYON   (France)

^b INSERM   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

^d CENTRE JEAN PERRIN   (France)

^e UNIVERSITÉ LYON 1   (France)

^f UNIVERSITÉ DE LYON   (France)

^g EDOUARD HERRIOT HOSPITAL   (France)

^h Nano H SAS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COVALENT COUPLINGS; GADOLINIUM CHELATES; GRAFTED NANOPARTICLES; IN-VITRO; MULTI-MODAL IMAGING; NANOMETRES; QUINOXALINE DERIVATIVES; SYNTHESISED;

GADOLINIUM; GRAFTING (CHEMICAL); NANOPARTICLES; SILICONES;

MELANIN;

GADOLINIUM; MELANIN; NANOMATERIAL;

ARTICLE; BINDING SITE; CHEMISTRY; MATERIALS TESTING; METHODOLOGY; PARTICLE SIZE; SURFACE PLASMON RESONANCE; ULTRASTRUCTURE;

BINDING SITES; GADOLINIUM; MATERIALS TESTING; MELANINS; NANOSTRUCTURES; PARTICLE SIZE; SURFACE PLASMON RESONANCE;

MLCS; MLOWN;

EID: 84875829880     PISSN: 20403364     EISSN: 20403372     Source Type: Journal    
DOI: 10.1039/c2nr33457g     Document Type: Article

References (59)

1. L. Finn S. N. Markovic R. W. Joseph Therapy for metastatic melanoma: the past, present, and future BMC Med. 2012 10 23
2. C. Garbe T. K. Eigentler U. Keilholz A. Hauschild J. M. Kirkwood Systematic review of medical treatment in melanoma: current status and future prospects Oncologist 2011 16 5 24
3. M. K. Khan N. Khan A. Almasan R. Macklis Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents OncoTargets Ther. 2011 4 137 148
4. A. P. Algazi C. W. Soon A. I. Daud Treatment of cutaneous melanoma: current approaches and future prospects Cancer Manage. Res. 2010 2 197 211
5. P. Lorigan T. Eisen A. Hauschild Systemic therapy for metastatic malignant melanoma-from deeply disappointing to bright future? Exp. Dermatol. 2008 17 383 394
6. J. A. Sosman K. B. Kim L. Schuchter R. Gonzalez A. C. Pavlick J. S. Weber G. A. McArthur T. E. Hutson S. J. Moschos K. T. Flaherty P. Hersey R. Kefford D. Lawrence I. Puzanov K. D. Lewis R. K. Amaravadi B. Chielowski H. J. Lawrence Y. Shyr F. Ye J. Li K. B. Nolop R. J. Lee A. K. Joe A. Ribas Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib N. Engl. J. Med. 2012 366 707 714
7. M. R. Middleton J. J. Grob N. Aaronson G. Fierlbeck W. Tilgen S. Seiter M. Gore S. Aamdal J. Cebon A. Coates B. Dreno M. Henz D. Schadendorf A. Kapp J. Weiss U. Fraass P. Statkevich M. Muller N. Thatcher Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma J. Clin. Oncol. 2000 18 158 166
8. 18F]fluorodeoxyglucose-positron emission tomography responses to vemurafenib in BRAF-mutant advanced melanoma J. Clin. Oncol. 2012 30 1628 1634
9. J. M. Chezal J. Papon P. Labarre C. Lartigue M. J. Galmier C. Decombat O. Chavignon J. Maublant J. C. Teulade J. C. Madelomont N. Moins Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4- iodobenzamide for imaging and targeted radionuclide therapy of melanoma J. Med. Chem. 2008 51 3133 3144
10. E. Dadachova J. D. Nosanchuk L. Shi A. D. Schweitzer A. Frenkel J. S. Nosanchuk A. Casadevall Dead cells in melanoma tumors provide abundant antigen for targeted delivery of ionizing radiation by a mAb to melanin Proc. Natl. Acad. Sci. U. S. A. 2004 101 no. 41 14865 14870
11. F. Lux A. Mignot P. Mowat C. Louis S. Dufort C. Bernhard F. Denat F. Boschetti C. Brunet R. Antoine P. Dugourd S. Laurent L. Vander Elst R. Muller L. Sancey V. Josserand J. L. Coll V. Stupard E. Barbier C. Rémy A. Broisat C. Ghezzi G. Le Duc S. Roux P. Perriat O. Tillement Ultrasmall rigid particles as multimodal probes for medical applications Angew. Chem., Int. Ed. 2011 50 12299 12303
12. G. Le Duc I. Miladi C. Alric P. Mowat E. Bräuer-Krisch A. Bouchet E. Khalil C. Billotey M. Janier F. Lux T. Epicier P. Perriat S. Roux O. Tillement Toward an image-guided microbeam radiation therapy using gadolinium based nanoparticles ACS Nano 2011 5 no. 12 9566 9574
13. J. L. Bridot D. Dayde C. Rivière C. Mandon C. Billotey S. Lerondel R. Sabattier G. Cartron A. Le Pape G. Blondiaux M. Janier P. Perriat S. Roux O. Tillement Hybrid gadolinium oxide nanoparticles combining imaging and therapy J. Mater. Chem. 2009 19 2328 2335
14. H. S. Choi W. Liu F. Liu K. Nasr P. Misra M. G. Bawendi J. V. Frangioni Design considerations for tumour-targeted nanoparticles Nat. Nanotechnol. 2010 5 42 47
15. A. S. Narang S. Varia Role of tumor vascular architecture in drug delivery Adv. Drug Delivery Rev. 2011 63 no. 8 640 658
16. H. S. Choi J. V. Frangioni Nanoparticles for biomedical imaging: fundamentals of clinical translation Mol. Imaging 2010 9 6 291 310
17. M. Benezra O. Penate-Medina P. B. Zanzonico D. Schaer H. Ow A. Burns E. DeStanchina V. Longo E. Herz S. Iyer J. Wolchok S. M. Larson U. Wiesner M. S. Bradbury Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma J. Clin. Invest. 2011 121 no. 7 2768 2780
18. K. Jimbow Y. Miyake K. Homma K. Yasuda Y. Izumi A. Tsutsumi S. Ito Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma Cancer Res. 1984 44 1128 1134
19. J. M. Wood K. Jimbow R. E. Boissy A. Slominski P. M. Plonka J. Slawinski J. Wortsman J. Tosk What's the use of generating melanin? Exp. Dermatol. 1999 8 153 164
20. K. Sono, D. Lye, C. A. Moore, W. C. Boyd, T. A. Gorlin and J. M. Belitsky, Melanin-based coatings as lead-binding agents, Bioinorg. Chem. Appl., 2012, article ID 361803
21. K. Wakamatsu S. Ito Advanced chemical methods in melanin determination Pigm. Cell Res. 2002 15 174 183
22. S. E. McClain K. B. Mayo A. L. Shada M. E. Smolkin J. W. Patterson C. L. Slingluff Jr Amelanotic melanomas presebting as red skin lesions: a diagnostic challenge with potentially lethal consequences Int. J. Dermatol. 2012 51 420 426
23. A. Premkumar F. Marincola J. Taubenberger C. Chow D. Venzon D. Schwartzentruber Metastatic melanoma: correlation of MRI characteristics and histopathology Chin. J. Magn. Reson. Imaging 1996 6 190 194
24. A. Dadachova J. D. Nosanchuk L. Shi A. D. Schweitzer A. Frenkel J. S. Nosanchuk A. Casadevall Dead cells in melanoma tumors provide abundant antigen for targeted delivery of ionizing radiation by a mAb to melanin Proc. Natl. Acad. Sci. U. S. A. 2004 101 14865 14870
25. E. Revskaya A. M. Jongco R. S. Sellers R. C. Howell W. Koba A. J. Guimaraes J. D. Nosanchuk A. Casadevall E. Dadachova Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine Clin. Cancer Res. 2009 15 2373 2379
26. T. Q. Pham I. Greguric X. Liu P. Berghofer P. Ballantyne J. Chapman F. Mattner B. Dikic T. Jackson C. Loc'h A. Katsifis Synthesis and evaluation of novel radioiodinated benzamides for malignant melanoma J. Med. Chem. 2007 50 3561 3572
27. 18F]fluorobenzamides as potential pet radiopharmaceuticals for melanoma imaging J. Labelled Compd. Radiopharm. 2011 54 312 317
28. 99mTc) complexes functionalized with melanin-binding pharmacophores New J. Chem. 2010 34 2564 2578
29. 123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging Eur. J. Nucl. Med. 2002 29 1478 1484
30. M. Eisenhut W. E. Hull A. Mohammed W. Mier D. Lay W. Just K. Gorgas W. D. Lehmann U. Haberkorn Redioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization J. Med. Chem. 2000 43 3913 3922
31. N. Desbois M. Gardette J. Papon P. Labarre A. Maisonial P. Auzeloux C. Lartigue B. Bouchon E. Debiton Y. Blache O. Chavignon J. C. Teulade J. Maublant J. C. Madelmont N. Moins J. M. Chezal Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma Bioorg. Med. Chem. 2008 16 7671 7690
32. R. M. Ings The melanin binding of drugs and its implications Drug Metab. Rev. 1984 15 1183 1212
33. 131I labelled potential agent Int. J. Cancer 2009 125 708 716
34. J. C. Madelmont; J. M. Chezal; O. Chavignon; J. C. Teulade; N. Moins, Labelled analogues of halobenzamides as radiopharmaceuticals, World patent, WO2008012782, 2008
35. K. Shanmuganathan J. H. Cho P. Iyer S. Baranowitz C. J. Ellison Thermooxidative stabilization of polymers using natural and synthetic melanins Macromolecules 2011 44 9499 9507
36. F. Bernsmann V. Ball F. Addiego A. Ponche M. Michel J. J. de Almeida Gracio V. Toniazzo D. Ruch Dopamine-melanin film deposition depends on the used oxidant and buffer solution Langmuir 2011 27 2819 2825
37. P. Merdith B. J. Powell J. Riesz S. P. Nighswander-Rempel M. R. Pederson E. G. Moore Soft Matter 2006 2 37 44
38. P. Meredith J. Riesz Radiative relaxation quantum yields for synthetic eumelanin Photochem. Photobiol. 2004 79 2 211 216
39. B. Liedberg C. Nylander I. Lundström Biosensing with surface plasmon resonance-how it all started Biosens. Bioelectron. 1995 10 i ix
40. S. Lin A. S. Y. Lee C. C. Lin C. K. Lee Determination of binding constant and stoichiometry for antibody-antigen interaction with surface plasmon resonance Curr. Proteomics 2006 3 271 282
41. D. A. Edwards Steric hindrance effects on surface reactions: applications to BIAcore J. Math. Biol. 2007 55 517 539
42. Y. Taguchi E. Takano T. Takeuchi SPR sensing of bisphenol a using molecularly imprinted nanoparticles immobilized on a slab optical waveguide with consecutive parallel Au and Ag deposition bands coexistent with bisphenol 1-immobilized Au nanoparticles Langmuir 2012 28 7083 7088
43. T. Ghosh L. Williams C. H. Mastrangelo Label-free detection of protein binding with multisine SPR microchips Lab Chip 2011 11 4194 4199
44. W. L. F. Armarego and D. D. Perrin, Purification of Laboratory Chemicals, ed., Butterworth, and, Heinemann, Reed educational and professional Publishing Ltd, Oxford, 4th edn, 1996
45. B. Johnsson S. Löfås G. Lindquist Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors Anal. Biochem. 1991 198 268 277
46. K. Q. Ling L. M. Sayre Discovery of a sensitive, and tightly binding fluorogenic substrate of bovine plasma amine oxidase J. Org. Chem. 2009 74 339 350
47. J. H. Jones W. J. Holtz E. J. Cragoe 6-Substituted 5-chloro-1,3-dihydro- 2H-imidazo[4,5-b]pyrazin-2-ones with hypotensive activity J. Med. Chem. 1973 16 537 542
48. D. Denoyer P. Labarre J. Papon E. Miot-Noirault M. J. Galmier J. C. Madelmont J. M. Chezal N. Moins Development of high-performance liquid chromatographic method for the determination of a new potent radioiodinated melanoma imaging and therapeutic agent J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2008 875 411 418
49. M. Alterman H. Sjöbom P. Säfsten P. O. Markgren U. H. Danielson M. Hämäläinen S. Läfas J. Hultén B. Classon B. Samuelsson A. Hallberg P1/P1′ modified HIV protease inhibitors as tools in two new surface plasmon resonance biosensor screening assays Eur. J. Pharm. Sci. 2001 13 203 212
50. L. You S. Feng R. An X. Wang D. Bai Silica gel accelerated aza-Michaël addition of amines to α,β-unsaturated amides Tetrahedron Lett. 2008 49 5147 5149
51. III complex with unusually large relaxivity J. Alloys Compd. 2004 374 298 302
52. R. B. Lauffer Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design Chem. Rev. 1987 87 901 927
53. A. Ghosh M. Haverick K. Stump X. Yang M. F. Tweedle J. E. Goldberger Fine-tuning the pH trigger of self-assembly J. Am. Chem. Soc. 2012 134 3647 3650
54. S. R. Bull M. O. Guler R. E. Bras T. J. Meade S. I. Stupp Self-assembled peptide amphiphile nanofibers conjugated to MRI contrast agents Nano Lett. 2004 5 1
55. A. G. Harrison K. W. M. Siu H. El Aribi Amide bond cleavage in deprotonated tripeptides: a newly discovered pathway to ′′b2 ions Rapid Commun. Mass Spectrom. 2003 17 869 875
56. C. A. Chang L. C. Francesconi M. F. Malley K. Kumar J. Z. Gougoutas M. F. Tweedle Synthesis, characterization and crystal structures of M(DO3A) (M = Fe, Gd) and Na[M(DOTA)] (M = Fe, Y, Gd) Inorg. Chem. 1993 32 3501 3508
57. F. M. Hwang H. Y. Chen P. S. Chen C. S. Liu Y. Chi C. F. Shu F. I. Wu P. T. Chou S. M. Peng G. H. Lee Iridium(iii) complexes with orthometalated quinoxaline ligands: subtle tuning of emission to the saturated red color Inorg. Chem. 2005 44 1344 1353
58. M. Borel D. Lafarge M. F. Moreau M. Bayle L. Audin N. Moins J. C. Madelmont High resolution magic angle spinning NMR spectroscopy used to investigate the ability of drugs to bind to synthetic melanin Pigm. Cell Res. 2005 18 49 54
59. L. Gautam K. S. Scott M. D. Cole Amphetamine binding to synthetic melanin and scatchard analysis of binding data J. Anal. Toxicol. 2005 29 339 344